Introduction
Congenital heart disease (CHD) is the second leading cause of death in Mexico's children under five years of age. Among them, malformations with univentricular physiology require close follow-up that should be guaranteed indefinitely, given the number of complications and the fast rate at which they occur, since they reduce the quality of life and life expectancy1.
Fontan surgery (FS) is the palliative surgical treatment indicated for univentricular CHD. This surgery shunts the flow from the superior and inferior venae cavae to the pulmonary artery (through a fenestrated or non-fenestrated tube). Therefore, a hemodynamic system that causes the systemic venous return is created to exclude the subpulmonary ventricle and connect directly to the pulmonary system, ensuring that the cardiac mass remains exclusively systemic. This procedure may be the first step towards cardiac transplantation; however, transplantation is not always accessible in Latin American countries2.
FS redistributes systemic venous return directly to the pulmonary circulation, causing pressure overload in the venous beds and in the splanchnic and lymphatic systems, which is a determining factor in developing diseases such as protein-losing enteropathy (PLE) and plastic bronchitis (PB). In addition, atrial overload and systemic ventricular morphology are arrhythmogenic phenomena and conditioners of heart failure. For these reasons, trained personnel in a hospital center should closely monitor such patients with the necessary infrastructure (complete imaging facilities, hemodynamic and electrophysiological study rooms, operating rooms, and intensive care areas)3.
In 2020, the pandemic caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) reached its first case in Mexico during the last week of February and spread logarithmically, affecting the working population and with higher lethality starting in the fifth decade of life.4 As a result, the national health system was forced to implement hospital conversion strategies prioritizing the greater availability of human and biomedical resources for the benefit of infected persons requiring hospitalization. Therefore, tertiary-level hospitals were the first to be used.
The reconversion of hospitals led to a group of people with specific diseases being displaced to a second plane, causing consultations, drug dispensing, tests, and procedures to be deferred. Hospitals caring for patients with ischemic heart disease with FS found themselves in this situation because they represented a small group5.
The objectives of this study were to evaluate the clinical consequences in patients with FS (complications of the disease, functional class) and the quality of care (follow-up, the performance of procedures, dispensing of medications) produced by hospital conversion due to the COVID-19 pandemic and to compare whether these variables were more frequent in the group of patients with FS failure, and to carry out an ethical discussion of these actions as well.
Methods
We conducted a comparative cross-sectional study in a captive cohort of patients with CHD of univentricular physiology repaired with FS in a tertiary care hospital in Mexico City. Patients in the initial cohort (those who initially signed the informed consent form) who accepted the telephone invitation to participate and filled out an online questionnaire were included; those with incomplete, duplicate, or inconsistent identification data were excluded. At the onset of Phase II of the SARS-CoV-2 pandemic response (March 24, 2020), mobility in Mexico City was restricted, and scheduled consultations were deferred or cancelled6. For this reason, on January 1, 2021, a medical appointment status update was initiated at the hospital where the study was conducted, and parents or guardians interested in the study were invited by telephone to provide their e-mail addresses to receive the link to the questionnaire on their children's status. The questionnaire asked about the following aspects:
– Attitudes adopted during quarantine: home confinement, place of residence during this period, physical activity, standard protective measures (distancing, masks, gloves, face shield), and updated vaccination status.
– Conditions for infection, including living with adults at high risk of exposure to infection or confirmed cases.
– Personal history of symptoms or exposure to the disease.
– Treatment: accessibility of medications, complications associated with drugs such as anticoagulants or antiplatelet agents.
– About the underlying disease: functional class, heart failure requiring hospitalization, consequences of deferral of scheduled procedures, and accessibility to reschedule new appointments.
Two comparison groups were selected based on FS functionality, considering as failure patients with cyanosis (oxygen saturation ≤ 90%), PLE, PB, or heart failure (systemic ventricular ejection fraction < 50%). In addition, the follow-up of patients in palliative care was particularized.
Statistical analysis
Qualitative variables were expressed as frequencies and percentages; quantitative variables were expressed as medians and interquartile ranges (p25-p75). Comparison between the two groups was performed with the χ2 test. The statistical software used was SPSS version 20 for MAC.
Results
Fifty-one patients met the selection criteria. The median age was 13 (6-18) years, and the median follow-up was 5 (1.2-12) years. The male: female ratio was 0.88:1.12. Tricuspid atresia was the most frequent malformation in 26 (51%) cases. Of the total, 21 (41%) patients presented some type of dysfunction, and the median functional class was II (I-IV). The remaining characteristics are shown in Table 1.
Variable | n | % |
---|---|---|
51 | ||
Sex | ||
Male | 24 | 47 |
Female | 27 | 53 |
Age (years)* | 13 | (6-18) |
Congenital heart disease | ||
Tricuspid atresia | 26 | 51 |
Pulmonary atresia without VSD | 13 | 25 |
Double entry into SV | 12 | 24 |
Time of the procedure (years) | 5 | 1.2-12 |
Medications | ||
Anticoagulants | 23 | 45 |
Antiplatelets | 40 | 78 |
ACEI | 19 | 37 |
Beta-blocker | 26 | 51 |
Digitalis | 2 | 4 |
Functional class * | II | (I-IV) |
Vaccines | ||
Influenza | 48 | 94 |
Pneumococcal | 43 | 84 |
Fontan system dysfunction | 21 | 41 |
Suspicion of SARS-CoV-2 | 6 | 12 |
Hospitalization | 3 | 6 |
*Median (25 and 75 percentiles).
ACEI, angiotensin-converting enzyme inhibitors; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SV, single ventricle; VSD, ventricular septal defect.
Subjects with and without FS dysfunction showed statistically significant differences (with a higher proportion of needs) in the first group in the following variables: uncontrolled anticoagulation (62% vs. 33%), additional expenditure for drug purchase, and hospitalization (95% vs. 30%), delay in laboratory tests (71% vs. 40%), CT scans (29% vs. 7%), Holter (24% vs. 13%), magnetic resonance imaging (MRI) (10% vs. 3%) and need for cardiac catheterization (33% vs. 7%). The remaining characteristics are shown in Table 2.
Total | Dysfunction | No dysfunction | p-values | ||||
---|---|---|---|---|---|---|---|
n | 51 | n | 21 | n | 30 | ||
State* | |||||||
Mexico City | 14 | 27 | 6 | 29 | 8 | 27 | NS |
Queretaro | 15 | 29 | 6 | 29 | 9 | 30 | NS |
Guerrero | 9 | 18 | 4 | 19 | 5 | 17 | NS |
Chiapas | 7 | 14 | 2 | 10 | 5 | 17 | NS |
Oaxaca | 3 | 6 | 2 | 10 | 1 | 3 | NS |
Puebla | 3 | 6 | 1 | 5 | 2 | 7 | NS |
Time of Fontan follow-up* | 9 | 18 | 6 | 4-8 | 3 | 1-6 | 0.05 |
Suspected SARS-CoV-2 | 7 | 14 | 3 | 14 | 4 | 13 | NS |
Contacts with SARS-CoV-2 | 4 | 8 | 2 | 10 | 2 | 7 | NS |
Modifications | |||||||
Insomnia | 13 | 25 | 6 | 29 | 7 | 23 | NS |
Weight gain | 10 | 20 | 3 | 14 | 7 | 23 | NS |
Increased cyanosis | 8 | 16 | 7 | 33 | 1 | 3 | NS |
Psychological counseling | 1 | 2 | 1 | 5 | 0 | 0 | NS |
Modifications | |||||||
Anticoagulation failure | 23 | 45 | 13 | 62 | 10 | 33 | 0.001 |
Pacemaker failure | 2 | 4 | 1 | 5 | 1 | 3 | NS |
Suspension of drug administration | 20 | 39 | 9 | 43 | 11 | 37 | NS |
Extra care expenses | 29 | 57 | 20 | 95 | 9 | 30 | < 0.0001 |
Metabolic dyscontrol | 8 | 16 | 5 | 24 | 3 | 10 | 0.001 |
Loss of follow-up | 46 | 90 | 19 | 90 | 27 | 90 | NS |
Hospitalization | 9 | 18 | 7 | 33 | 2 | 7 | NS |
Loss of studies or follow-up | |||||||
Laboratory | 27 | 53 | 15 | 71 | 12 | 40 | 0.001 |
CT scan | 8 | 16 | 6 | 29 | 2 | 7 | < 0.0001 |
Holter | 9 | 18 | 5 | 24 | 4 | 13 | 0.001 |
Magnetic resonance imaging | 3 | 6 | 2 | 10 | 1 | 3 | 0.001 |
Cardiac catheterization | 9 | 18 | 7 | 33 | 2 | 7 | 0.0001 |
Clinical consequences | |||||||
Impairment of functional class* | 4 | 8 | 3 | 14 | 1 | 3 | 0.001 |
χ2 test,
*Mann Whitney U-test.
NS, non-significant; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
In terms of mobility, all patients reported having stayed in confinement, following the health authorities' recommendations: 14% reported having been in contact with a person with suspected SARS CoV-2 infection and 8% with a confirmed case. However, none of the FS patients became infected. Furthermore, 25% reported sleep disturbance, and 20% reported an increase in body weight.
The two patients in the palliative care program discontinued care from the moment of hospital reconversion and did not receive medication for symptom control (analgesics, sedatives, antidepressants, and oxygen). No patients have died to date.
Discussion
This article discusses some of the bioethical dilemmas of health care delivery in pediatric patients with rare diseases in the context of the COVID-19 pandemic. Health authorities and health professionals have made decisions that prioritize the distribution of human and technological resources based on ethical and moral arguments—for example, identifying the conditions of the vulnerability of patients infected by SARS-Cov-2 and placing them at the forefront of care. Unfortunately, this decision implies that hospitals treating rare diseases but with a high demand for specialized services have had to stop caring for these patients to reduce population demand due to the severe conditions caused by SARS-CoV-2.
Patients with CHD, specifically those with a cardiac malformation with univentricular physiology, require medical consultations with a narrow window of time to identify and treat early complications secondary to cyanosis, thrombosis, heart failure, pacemaker generator depletion to maintain quality of life. In addition, there is a deficit in the care of patients with univentricular physiology because national life expectancy and the possibility of cardiac transplantation are lower than in other countries6,7.
In a pandemic, such as the current one, four necessary epidemiological actions can be distinguished: containment, deferral, research, and mitigation, which will be discussed below8:
– In the containment phase, there are problems of restriction of fundamental human rights, such as freedom of movement and the performance of daily activities (such as working or going to school). The limitation of the population's mobility with forced home isolation is intended to prevent the spread of the virus. The principle of equity prevails since protecting at-risk groups requires the inhabitants to show solidarity, even sacrificing their autonomy to obtain a primary common good. This principle applies specifically to patients with FS, considering that there are nine public hospitals with experience in performing total cavopulmonary bypass in Mexico. Seven are located in Mexico City (national epidemic center of the pandemic), which were all converted to care for patients with COVID-199.
– In the deferral stage, each country decides the degree of restriction it imposes on its inhabitants and evaluates it based on scientific evidence of the behavior of the disease. With these arguments, the impact on public health and the insurmountable limits of each right are weighed—for example, isolating patients from their families in hospitalization areas10.
– Research phase. This crisis demonstrated the urgency of having treatments and vaccines available, despite the significant mismatch between the time of the methodological phases of the research work and the needs of the populations affected by the virus. Specifically, in vaccine research, vaccine efficacy and safety analysis was reduced to the shortest possible time to initiate an application to the population. This situation limits research in pediatric groups and forces decisions to be made, such as not including children in the vaccination program.
– The mitigation phase consists of allocating resources, which will always be scarce or insufficient, depending on the needs. In the context of the COVID-19 pandemic, beds with oxygen intakes and intensive care units with mechanical ventilators, indispensable for treating patients undergoing surgery, such as patients with FS, were required on a massive scale. Due to this situation, such procedures were deferred9. As a result, the dynamics of our patients' medical care changed in these months of the pandemic, some of them in an unrecoverable therapeutic window of opportunity that could leave irreversible sequelae9.
Health strategies must address not only the medical dimensions of the epidemic, although they are a priority, but also human rights and the specific consequences of each pathology. Healthcare must remain available to all people without discrimination or exclusion. When making decisions on the distribution of services, different approaches must be considered. The utilitarian approach (understood as maximizing the benefit for the most significant number of people for the longest possible time) prioritizes care for adults (as the group with the highest number of infections) over pediatric populations. There is also the dilemma bias, the search for quick solutions without ethical commitment to solving health problems8. Both point to a high-risk situation in which the rights of individuals can easily be violated, as individual benefits are subordinated to collective ones. The classic concept includes the maximization of collective benefits11.
In a community, individual human rights cannot be subordinated to the maximization of collective benefits. PAHO (Pan American Health Organization) has stated that, in the Americas, the level of neglect of other diseases, such as diabetes, hypertension, heart disease, among others, has been devastating. Therefore, implementing a process of regularization or return to normality to correct the delay in providing follow-up consultations, pending diagnoses, treatments, and rehabilitation displaced by the hospital conversion7 has been planned by the different health institutions in Mexico. In personalism, every human being is a “person with the dignity of his or her own,” who cannot be impoverished by social and medical conditions so that another person or society can neglect no life. Personalism reminds the healthcare professional that all human beings have the same value and dignity12.
Pediatric diseases, in this case, CHD of univentricular physiology, are always a family problem, so that the parents of patients with this pathology have experienced the hospital conversion and the deferral of follow-up of their children's pathology with particular anxiety. In addition, the economic impact has been significant even for the purchase of the necessary medications. The parents of these children are aware that constant monitoring and medical care are required and have experienced this situation as a radical change in the care, plans, priorities, and even in the expression of their children's emotions. Although there are no cohort studies of patients with CHD evaluating the consequences of COVID-19 or limited access to health services, cyanosis (due to the risk of thrombosis), arrhythmias, and ventricular dysfunction have been identified as poor prognostic variables that justify continuity of healthcare services13.
The United Nations Secretary-General has expressed the lack of care for children with chronic diseases, citing: “I am particularly concerned about the welfare of the world's children in this pandemic,” and has made an urgent appeal to the leaders of all countries to protect the rights of children and safeguard their well-being12.
With the reconversion of high specialty hospitals, where only patients with COVID-19 have been treated, and the suspension of follow-up consultations for chronic patients, especially children with severe pathologies such as CHD with FS, the four main principles of bioethics have been affected (Table 3)14.
Principle | Ensure | Pandemic context |
---|---|---|
Autonomy | Guarantee the “best interests of the child,” in which
health-related decisions are executed under the direction of parents
or guardians and health personnel. The State must provide children with the guarantee of their physical and emotional development, executed by parents under the Child's Rights. It should be privileged as long as it does not harm other people |
Parents' activities were impaired because they could not comply with established schedules for consultations, laboratory or cabinet studies, and dispensing of medications due to lack of freedom to make decisions, confinement, and limited access to medical care |
Beneficence | Guarantee the moral obligation to act for the benefit of others, cure harm, and promote good or welfare without discrimination to not generate inequalities. Beneficence must be balanced against potential harm. The absence of medical care should be avoided | There is a lack of healthcare services to care for vulnerable groups. The pandemic has highlighted patient selection for treatment, vaccines, and intensive care, among others |
Non-maleficence | Ensure the oldest principle of medical practice: first, not harm (“primum non nocere”), prevent harm and preserve life | An adequate public policy was not created to guarantee the articulated administration of goods and services. It was impossible to offer the “minimum” that corresponds to these patients. This principle was not complied with due to the magnitude of the health crisis |
Justice | Ensure equity in the distribution of costs and
benefits, the distribution of resources according to needs must be
possible for all. Give to each one what is due to him/her.
Distributive justice, according to Aristotle, means what is just or right concerning the allocation of goods in a society. The first principle of distributive justice is known as egalitarianism, which consists of giving an equal amount of goods to members of society. Equity seeks to implement justice and equality of opportunity, respecting the particular characteristics of the individual to give each one what is due to him/her |
The pandemic forced decision-making by applying public policies to favor the care of those infected by COVID-19 (positive discrimination or affirmative action), even using resources that correspond to other patients (such as those that underwent Fontan surgery) |
Finally, the following conclusions are mentioned:
– Bioethics training for healthcare professionals and leaders who make decisions at the global, national, and institutional levels should be prioritized since these bioethical dilemmas arise daily and are latent in times of crisis such as this pandemic.
– Continuity of care must be guaranteed, even in times of health crises. Chronic patients cannot be displaced because the principles of autonomy, beneficence, and non-maleficence must be preserved. Similarly, equity in treatment highlights the strength of healthcare systems since displaced patients are practically left to die, and decision-makers must ask themselves whether it is reasonable to underestimate these groups.
– For now, the priority is to address the devastation caused by the pandemic. Once the crisis is over, public services must return to guaranteeing equal care for all groups, including the most vulnerable, such as children with CHD with and without surgery, for an elementary reason of justice.